| http://www.w3.org/ns/prov#value | - To ensure safety, regulatory agencies, such as Food and Drug Administration (FDA), requirethat protein-based pharmaceutical products are substantially free from impurities, including both product related contaminants such as aggregates, fragments and variants of the recombinant protein and process related contaminants such as host cellproteins, media components, viruses, DNA and endotoxins.
|
